Cargando…

Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans

INTRODUCTION: CD4 T lymphocytes remain the surrogate measure for monitoring HIV progress in resource-limited settings. The absolute CD4 cell counts form the basis for antiretroviral therapy (ART) initiation and monitoring among HIV-infected adults. However, the rate of CD4 cell change differs among...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nanzigu, Sarah, Kiguba, Ronald, Kabanda, Joseph, Mukonzo, Jackson K, Waako, Paul, Kityo, Cissy, Makumbi, Fred
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857165/ https://www.ncbi.nlm.nih.gov/pubmed/24348073 http://dx.doi.org/10.2147/HIV.S50614

Ejemplares similares

Antiretroviral drugs found in pork on Ugandan market: Implications for HIV/AIDS treatment
por: Nakato, Ritah, et al.
Publicado: (2020)

Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study
por: Mukonzo, Jackson K, et al.
Publicado: (2013)

An Evaluation of Antibiotic Prescription Rationality at Lower Primary Healthcare Facilities in Three Districts of South-Western Uganda
por: Nantongo, Hanifah, et al.
Publicado: (2022)

Blood glucose outcomes of anti-retroviral therapy naïve Ugandan people with HIV with pre-diabetes mellitus initiated on dolutegravir for 48 weeks
por: Mulindwa, Frank, et al.
Publicado: (2023)

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts
por: Bajunirwe, Francis, et al.
Publicado: (2018)

Herbal medicine use and linked suspected adverse drug reactions in a prospective cohort of Ugandan inpatients
por: Kiguba, Ronald, et al.
Publicado: (2016)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients
por: Kiguba, Ronald, et al.
Publicado: (2017)

Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda
por: Kiguba, Ronald, et al.
Publicado: (2015)

Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults
por: Lamorde, Mohammed, et al.
Publicado: (2012)

Comparison of Immunological and Virological Recovery with Rapid, Early, and Late Start of Antiretroviral Treatment in Naive Plwh: Real-World Data
por: Sarıgül Yıldırım, Figen, et al.
Publicado: (2023)

Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel
por: Munkwase, Grant, et al.
Publicado: (2017)

Empiric Deworming and CD4 Count Recovery in HIV-Infected Ugandans Initiating Antiretroviral Therapy
por: Lankowski, Alexander J., et al.
Publicado: (2014)

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
por: Lamorde, M
Publicado: (2012)

Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2023)

Rare, Serious, and Comprehensively Described Suspected Adverse Drug Reactions Reported by Surveyed Healthcare Professionals in Uganda
por: Kiguba, Ronald, et al.
Publicado: (2015)

Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants
por: Kiguba, Ronald, et al.
Publicado: (2014)

Chewing-Stick Practices Using Plants with Anti-Streptococcal Activity in a Ugandan Rural Community
por: Odongo, Charles Okot, et al.
Publicado: (2011)

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children
por: Kityo, Cissy, et al.
Publicado: (2017)

Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine–Pyrimethamine Disposition Among Ugandan Pregnant Women
por: Odongo, Charles O., et al.
Publicado: (2015)

Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting
por: Kiguba, Ronald, et al.
Publicado: (2020)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2016)

Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV
por: Fitzgerald, Felicity C, et al.
Publicado: (2019)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study
por: Inzaule, Seth C., et al.
Publicado: (2017)

Rates and Correlates of Short Term Virologic Response among Treatment-Naïve HIV-Infected Children Initiating Antiretroviral Therapy in Ethiopia: A Multi-Center Prospective Cohort Study
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2019)

Pharmacogenetic-Based Efavirenz Dose Modification: Suggestions for an African Population and the Different CYP2B6 Genotypes
por: Mukonzo, Jackson K., et al.
Publicado: (2014)

Influence of parents’ and caregivers’ characteristics on the outcomes of antiretroviral treatment in Ugandan children
por: Malangu, Ntambwe
Publicado: (2011)

Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
por: Kasirye, Ronnie P., et al.
Publicado: (2017)

Host HLA B*Allele-Associated Multi-Clade Gag T-Cell Recognition Correlates with Slow HIV-1 Disease Progression in Antiretroviral Therapy-Naïve Ugandans
por: Serwanga, Jennifer, et al.
Publicado: (2009)

Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults
por: Mulindwa, Frank, et al.
Publicado: (2023)

Measuring adherence to antiretroviral treatment in resource-poor settings: The feasibility of collecting routine data for key indicators
por: Chalker, John C, et al.
Publicado: (2010)

Eating away from home is associated with overweight and obesity among Ugandan adults: the 2014 Uganda non-communicable disease risk factor survey
por: Kityo, Anthony, et al.
Publicado: (2022)

1284. Study of Single Nucleotide Polymorphisms Associated with HIV-1 Set-Point Viral Load in Antiretroviral Therapy-Naïve HIV-Positive Participants of the START Study
por: Ekenberg, Christina, et al.
Publicado: (2018)

Impact of adverse events of antiretroviral treatment on regimen change and mortality in Ugandan children
por: Malangu, Ntambwe, et al.
Publicado: (2010)

Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children
por: Parikh, Sunil, et al.
Publicado: (2016)

Milk Calcium and Phosphorus in Ugandan Women with HIV on Tenofovir-Based Antiretroviral Therapy
por: Nabwire, Florence, et al.
Publicado: (2023)

Potential drug–drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals
por: Mukonzo, Jackson, et al.
Publicado: (2019)

Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults
por: Mulindwa, Frank, et al.
Publicado: (2023)

Healthcare professionals’ perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda
por: Ndagije, Helen Byomire, et al.
Publicado: (2020)

Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir
por: Mulindwa, Frank, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1jpepgsuib38lphu0bres0mg7v